Intervention not reported
Any serious adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Cytokine release syndrome ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Progression‐free survival ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Complete response ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Death Analysis 1.1 · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy showed no clear difference in death from all causes ‐ modified ITT analysis compared with control (moderate certainty).
1 finding from 1 review
Incidence of oesophageal squamous cell carcinoma ‐ modified ITT analysis · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy showed no clear difference in incidence of oesophageal squamous cell carcinoma ‐ modified ITT… compared with control (moderate certainty).
1 finding from 1 review
Adverse events · healthy asymptomatic H. pylori‐infected individuals
1 finding from 1 review
Intervention not reported
Treatment failure day‐28 PCR‐adjusted(PP population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failure day‐28 PCR‐adjusted(PP population) (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failureday‐28 PCR‐adjusted(ITT population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failureday‐28 PCR‐adjusted(ITT population) (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Drug‐related adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention probably leads to lower drug‐related adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Drug‐related vomiting · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in drug‐related vomiting (low certainty).
1 finding from 1 review
Intervention not reported
Acceptability · children aged 14 years or younger with uncomplicated P falciparum malaria
1 finding from 1 review
Adverse events (number) Asymptomatic hypercalcaemia and hypercalciuria
It is very uncertain whether vitamin D plus calcium changes adverse events (number) Definition: asymptomatic hypercalcaemia and… compared with vitamin D (very low certainty).
1 finding from 1 review
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Growth pattern
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Socioeconomic effects
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Morbidity (number) Definition: fractures
It is very uncertain whether vitamin D plus calcium changes morbidity (number) Definition: fractures compared with calcium (very low certainty).
1 finding from 1 review
Adverse events (number) Asymptomatic hypercalcaemia and hypercalciuria
It is very uncertain whether vitamin D plus calcium changes adverse events (number) Asymptomatic hypercalcaemia and hypercalciuria compared with calcium (very low certainty).
1 finding from 1 review